Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$184K Sell
12,566
-20,135
-62% -$295K ﹤0.01% 1531
2025
Q4
$413K Buy
+32,701
New +$482K ﹤0.01% 1378
2023
Q1
Sell
-29,503
Closed -$507K 2000
2022
Q4
$507K Buy
+29,503
New +$523K ﹤0.01% 1482

Other funds holding RXO

Guggenheim Capital's RXO Position: Q1 2026 in Review

Guggenheim Capital reduced its RXO (RXO) stake by 62% in Q1 2026, selling an estimated $295K and leaving 12,566 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #1531.

Guggenheim Capital first reported a position in RXO in Q4 2022 and has held it in 3 quarters since. The position peaked at $507K in Q4 2022. 274 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Guggenheim Capital held 12,566 shares of RXO worth $184K as of Q1 2026.
  • Guggenheim Capital sold 20,135 RXO shares in Q1 2026, an estimated $295K.
  • RXO made up ﹤0.01% of Guggenheim Capital's portfolio in Q1 2026, its #1531 holding.
  • Guggenheim Capital first reported a position in RXO in Q4 2022 and has held it in 3 quarters since.
  • Guggenheim Capital's RXO position peaked at $507K in Q4 2022.
  • 274 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Guggenheim Capital's 13F filing for Q1 2026, filed 15 May 2026.